Bacterial vaginosis, commonly called BV, is the most common cause of vaginitis in the United States and in many populations worldwide. It edges out vulvovaginal candidiasis (yeast infections) by a slim margin, with both conditions far outpacing trichomoniasis. But the picture is more layered than a simple ranking suggests, because non-infectious causes like hormonal changes after menopause also produce vaginitis symptoms, and self-diagnosis turns out to be surprisingly unreliable.
How the Three Main Infectious Causes Stack Up
Researchers have long grouped infectious vaginitis into three categories: bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. Epidemiological data from the United States and Scandinavia consistently places BV at the top, affecting a broader range of women than even gonorrhea.1PubMed. Epidemiology of vaginitis A more recent multicenter study found BV in about 23% of women presenting with vaginitis symptoms, yeast infections in roughly 22%, and trichomoniasis in only about 2%.2PubMed Central. Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis So BV and yeast infections are nearly tied in prevalence among symptomatic women, with BV holding a consistent but narrow lead.
That near-tie matters clinically, because the two conditions feel different, smell different, and require completely different treatments. Treating a yeast infection when you actually have BV, or vice versa, wastes time and money and can make symptoms worse. The gap between BV and yeast infections is small enough that neither condition should be assumed without some form of testing.
What Happens in Bacterial Vaginosis
BV is not a single-organism infection the way strep throat is. It is a shift in the entire vaginal microbial community. Normally, the vagina is dominated by Lactobacillus bacteria that produce lactic acid, keeping the environment acidic and inhospitable to many pathogens.3PubMed Central. Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique? In BV, those protective lactobacilli get displaced by a mixed community of anaerobic bacteria, and the vaginal pH rises.
What makes BV particularly stubborn is the formation of a biofilm on the vaginal lining. Several species of bacteria grow together in a structured, slime-like layer that adheres to vaginal cells. Research using fluorescent imaging has confirmed that these biofilms are dominated by Gardnerella species, with other bacteria like Atopobium vaginae embedded within them.4PLOS ONE. Unravelling the Bacterial Vaginosis-Associated Biofilm: A Multiplex Gardnerella vaginalis and Atopobium vaginae Fluorescence In Situ Hybridization Assay Using Peptide Nucleic Acid Probes This biofilm structure is central to understanding why BV keeps coming back after treatment, a problem covered later in this article.
Symptoms of BV typically include a thin, grayish-white discharge with a fishy odor that tends to be more noticeable after sex. Some women with BV have no symptoms at all, which complicates things because untreated BV carries real health risks even when it feels like nothing is wrong.
Yeast Infections Are Almost as Common
Vulvovaginal candidiasis is caused by an overgrowth of Candida fungus, most often Candida albicans. Unlike BV, this is not a shift in the bacterial community but a takeover by a single organism that normally lives in the vagina at low levels. An estimated three out of four women of childbearing age will have at least one yeast infection in their lifetime.5PLoS Pathogens. Candida Vaginitis: When Opportunism Knocks, the Host Responds The symptoms are distinct from BV: thick, white, cottage-cheese-like discharge with intense itching, burning, and sometimes swelling of the vulva.
For most women a yeast infection is a one-off nuisance, but a meaningful minority develop recurrent episodes. Estimates suggest that roughly 5 to 9% of women experience four or more episodes per year, a condition that can be genuinely debilitating and often requires ongoing antifungal maintenance therapy.6PubMed Central. Recurrent Vulvovaginal Candidiasis: An Immunological Perspective The immune system’s response to Candida plays a large role in who develops recurrent disease and who clears it quickly, and researchers are still working out why some women’s immune responses fail to keep the fungus in check.
Trichomoniasis Is Rarer but Often Overlooked
Trichomoniasis is caused by Trichomonas vaginalis, a single-celled parasite transmitted through sexual contact. It is a true sexually transmitted infection, unlike BV and yeast infections, which are not typically classified that way. The parasite attaches to the cells lining the genital tract using surface proteins and then releases enzymes that damage tissue and trigger inflammation.7PubMed Central. Trichomoniasis Symptoms can include a frothy yellow-green discharge with a strong odor, irritation, and pain during urination or sex, though many cases are asymptomatic.
Because trichomoniasis accounts for only a small fraction of vaginitis cases in many clinical settings, it sometimes gets missed when clinicians focus on BV and yeast as the likely culprits. Treatment is straightforward with oral antibiotics, but sexual partners need to be treated simultaneously or reinfection is virtually guaranteed.
Non-Infectious Vaginitis Deserves More Attention
Not all vaginitis is caused by an infection. After menopause, dropping estrogen levels cause the vaginal lining to thin, dry out, and become inflamed, a condition called atrophic vaginitis. The tissue becomes fragile and prone to irritation, producing symptoms that can mimic infection: burning, itching, painful sex, and even urinary problems like urgency and frequency.8PubMed. Management of post-menopausal vaginal atrophy and atrophic vaginitis The change in vaginal pH that accompanies estrogen loss also makes postmenopausal women more vulnerable to urinary tract infections.9PubMed. Postmenopausal vaginal atrophy and atrophic vaginitis
Atrophic vaginitis is extremely common, yet many women and clinicians either don’t discuss it or mistake it for an infection. Treatment focuses on restoring estrogen locally, usually with vaginal creams or rings, rather than antibiotics or antifungals. Another underrecognized entity is aerobic vaginitis, which involves a different set of bacteria than BV and occurs in an estimated 7 to 12% of women. It remains widely underdiagnosed despite growing clinical awareness.
Why Self-Diagnosis Fails So Often
One of the biggest practical problems with vaginitis is that women frequently guess wrong about what they have. A study of military women found that self-diagnostic accuracy was only about 56% for BV and trichomoniasis, and around 69% for yeast infections.10PubMed Central. Accuracy of Vaginal Symptom Self-Diagnosis Algorithms for Deployed Military Women That means roughly a third to nearly half the time, women who self-treated would have been using the wrong medication. False positives led to unnecessary treatment about 8 to 20% of the time depending on the condition, and false negatives meant about a quarter of infections went untreated.
This is partly because BV, yeast infections, and trichomoniasis share overlapping symptoms like discharge and irritation. The classic textbook descriptions (fishy odor for BV, cottage-cheese discharge for yeast) are real but not as reliable as people think. Newer molecular diagnostic panels can simultaneously test for all three conditions from a single vaginal swab, with sensitivity and specificity above 90% across the board.11PubMed Central. Clinical Evaluation of a New Molecular Test for the Detection of Organisms Causing Vaginitis and Vaginosis12PubMed. Accuracy of the BD MAXâ„¢ vaginal panel in the diagnosis of infectious vaginitis These tests take much of the guesswork out of diagnosis and are becoming more widely available, including in point-of-care settings.
How Lactic Acid Keeps Things in Balance
The vaginal microbiome in a healthy state is unusual compared to most body sites: rather than hosting a diverse mix of bacteria, it tends to be dominated by just one or a few species of Lactobacillus. These bacteria ferment glycogen from vaginal cells into lactic acid, driving the pH down to around 3.5 to 4.5. Research has confirmed a strong linear relationship between the concentration of lactic acid and vaginal acidity, with lactic acid essentially being the main driver of how acidic the environment is.13PLOS ONE. Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
When something disrupts those lactobacilli, lactic acid drops, pH rises, and opportunistic organisms gain a foothold.14PubMed. The role of lactic acid production by probiotic Lactobacillus species in vaginal health This is the core mechanism behind BV: a collapse of Lactobacillus dominance followed by blooming of anaerobic bacteria. Hormonal fluctuations during the menstrual cycle, use of hormonal contraceptives, and even diet and exercise have all been shown to influence how much Lactobacillus populates the vagina day to day.15PubMed Central. Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise The vaginal microbiome is not a static thing; it shifts constantly, and those shifts sometimes tip the balance toward infection.
Douching and Other Behavioral Triggers
Among the modifiable risk factors for vaginitis, vaginal douching is the most thoroughly studied and the most consistently harmful. Douching is known to cause vaginal dysbiosis and predispose women to BV, pelvic inflammatory disease, and preterm birth.16PubMed Central. The Vaginal Microbiome in Health and Disease-What Role Do Common Intimate Hygiene Practices Play? Lab research on common douching products, including vinegar-based, iodine-based, and baking-soda-based solutions, found that all of them killed vaginal epithelial cells and could reduce the protective effects of beneficial lactobacilli.17PubMed Central. Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses
Despite decades of public health messaging, douching remains common in some communities. Other behavioral factors linked to vaginitis include use of scented soaps or sprays in the genital area, wearing tight non-breathable clothing for prolonged periods, and antibiotic use that incidentally kills protective vaginal bacteria. None of these is as well-documented as douching, but they follow the same logic: anything that disrupts the Lactobacillus-dominated environment opens the door to infection.
BV During Pregnancy
Bacterial vaginosis carries particular risks during pregnancy. BV has been linked to preterm delivery, early miscarriage, postpartum endometritis, and low birth weight.18PubMed. Effect of bacterial vaginosis on preterm birth: a meta-analysis A meta-analysis found that the overall risk of preterm birth was roughly 1.4 to 1.8 times higher in women with BV compared to women without it.19PubMed. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant The U.S. Preventive Services Task Force has reviewed the evidence on screening pregnant women for BV but has not issued a blanket recommendation for universal screening, in part because treating BV during pregnancy has not consistently been shown to prevent preterm birth in all populations.20JAMA. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement
The biofilm-driven nature of BV may explain why treating it in pregnancy does not always improve outcomes. If the biofilm reforms quickly after a course of antibiotics, the dysbiotic environment returns before the pregnancy reaches term. This is an active area of research, and the guidelines may shift as better treatment strategies emerge.
BV Raises Susceptibility to Other Infections
BV does more than cause discharge and odor. Women with the most severe forms of BV, as measured by laboratory scoring, face nearly three times the risk of acquiring a sexually transmitted infection compared to women with normal vaginal flora.21PubMed Central. Severity of Bacterial Vaginosis and the Risk of Sexually Transmitted Infection BV has been associated with increased susceptibility to HIV, among other viral infections.22PubMed Central. Impact of bacterial vaginosis on sexually transmitted viral infections: a bacterial point of view
The reasons are not entirely settled, but they likely involve the loss of the protective acid barrier, the inflammation that BV-associated bacteria trigger, and the disruption of immune defenses on the vaginal surface. This elevated STI risk gives BV an outsized public health impact beyond the immediate discomfort it causes.
Why BV Keeps Coming Back
Recurrence is arguably the most frustrating feature of BV. After standard antibiotic treatment, more than 60% of women experience a return of BV.23PubMed Central. The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment The biofilm is a major reason. Even after antibiotics wipe out most of the free-floating bacteria, bacteria sheltered within the biofilm can survive because the biofilm’s matrix acts as a physical shield, blocking drug penetration. These survivors then repopulate the vagina quickly once treatment ends.24Indian Journal of Dermatology, Venereology and Leprology. Bacterial vaginosis and biofilms: Therapeutic challenges and innovations – A narrative review
There is also growing evidence that BV-associated bacteria are exchanged between sexual partners. A recent trial published in the New England Journal of Medicine explored whether treating male partners with antibiotics could reduce BV recurrence in women, based on the observation that BV-associated organisms can be detected in the penile microbiome.25PubMed. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis This line of research represents a shift in how clinicians think about BV: not purely as an internal microbiome disruption, but as something that may involve ongoing microbial exchange with a partner.
Emerging Treatments
Given how often standard antibiotics fail to prevent BV recurrence, researchers have been exploring more creative approaches. One of the most talked-about is vaginal microbiota transplantation, essentially transferring vaginal fluid from a healthy donor to a woman with recurrent BV in order to re-establish a Lactobacillus-dominated community. An early case series treated five women with intractable BV; four of them achieved full long-term remission after VMT, with follow-up ranging from five to 21 months, and no adverse effects were observed.26Nature Medicine. Vaginal microbiome transplantation in women with intractable bacterial vaginosis Three of those four required more than one transplant, including one who needed a switch to a different donor, before the new microbial community took hold.
VMT is still experimental and far from standard practice. Questions about donor screening, standardization, long-term safety, and scalability remain open.27PubMed Central. Vaginal microbiota transplantation is a truly opulent and promising edge: fully grasp its potential But the concept is appealing precisely because it targets the root problem: restoring the microbial ecosystem rather than just killing off the bad actors and hoping the good ones move back in on their own.
The Vaginal Microbiome Varies by Ethnicity
One complication in defining what a “normal” vaginal microbiome looks like is that the composition differs across ethnic groups. A landmark study found that the vaginal communities of reproductive-age women clustered into five main types. Four were each dominated by a single Lactobacillus species, and the fifth had lower Lactobacillus levels and more anaerobic bacteria. The proportions of each community type varied significantly by ethnicity, with Hispanic and Black women more likely to harbor the more diverse, less Lactobacillus-dominated community type, and Asian and white women more likely to be Lactobacillus-dominant. Average vaginal pH was also higher in Hispanic and Black women.28PubMed Central. Vaginal microbiome of reproductive-age women
This does not mean that women with less Lactobacillus are unhealthy. Many women in the fifth community type are completely asymptomatic and show no signs of BV. These findings have pushed researchers to argue for a more refined definition of a “normal” vaginal microbiome, one that accounts for individual and ethnic variation rather than treating any deviation from Lactobacillus dominance as pathological.29PubMed Central. Insights into the vaginal microbiome in a diverse group of women of African, Asian and European ancestries The clinical implication is meaningful: diagnostic criteria for BV that rely heavily on the presence or absence of Lactobacillus may overcall disease in some populations and undercall it in others. It is an area where the science is still catching up to the biological reality.